Predictors of Axillary Complete Pathologic response in Hormone Receptor Positive, HER2 Negative Clinically Node-Positive Breast Cancer
{{output}}
Objective: Neoadjuvant therapy can downstage the axilla, reducing the need for an axillary dissection. In addition, obtaining a complete pathologic response in the axilla is associated with a better 10 year overall survival. Our ... ...
